ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 237 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $545,000 | -61.2% | 7,992 | -60.6% | 0.01% | -61.8% |
Q1 2021 | $1,406,000 | -22.1% | 20,267 | -13.7% | 0.03% | -10.5% |
Q4 2020 | $1,804,000 | +585.9% | 23,482 | +567.5% | 0.04% | +533.3% |
Q3 2020 | $263,000 | +113.8% | 3,518 | +80.1% | 0.01% | +100.0% |
Q2 2020 | $123,000 | -70.9% | 1,953 | -88.2% | 0.00% | -70.0% |
Q3 2017 | $422,000 | – | 16,568 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |